Omada Health, Inc. (NASDAQ:OMDA – Get Free Report) President Wei-Li Shao sold 4,036 shares of the firm’s stock in a transaction on Thursday, September 10th. The stock was sold at an average price of $21.85, for a total value of $88,186.60. Following the sale, the president directly owned 295,313 shares in the company, valued at $6,452,589.05. The trade was a 1.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.
Wei-Li Shao also recently made the following trade(s):
- On Wednesday, August 12th, Wei-Li Shao sold 8,866 shares of Omada Health stock. The stock was sold at an average price of $25.02, for a total value of $221,827.32.
Omada Health Trading Up 0.5%
NASDAQ:OMDA opened at $19.76 on Thursday. Omada Health, Inc. has a 1 year low of $10.28 and a 1 year high of $26.92. The stock has a 50-day moving average price of $22.45 and a two-hundred day moving average price of $18.14. The stock has a market cap of $1.21 billion, a price-to-earnings ratio of 395.20 and a beta of 1.86.
Analyst Ratings Changes
Several research analysts have recently weighed in on the stock. Citigroup reiterated an “outperform” rating on shares of Omada Health in a report on Friday, August 14th. Robert W. Baird raised their price objective on shares of Omada Health from $15.00 to $25.00 and gave the stock a “neutral” rating in a report on Wednesday, August 12th. Citizens Jmp boosted their price objective on shares of Omada Health from $27.00 to $32.00 and gave the company a “market outperform” rating in a research report on Friday, August 14th. Weiss Ratings raised shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Finally, Canaccord Genuity Group increased their target price on Omada Health from $24.00 to $28.00 and gave the stock a “buy” rating in a report on Tuesday, July 21st. Eleven analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $26.67.
Check Out Our Latest Analysis on Omada Health
Hedge Funds Weigh In On Omada Health
Several hedge funds have recently made changes to their positions in the business. Walleye Capital LLC bought a new position in Omada Health in the second quarter valued at $11,648,000. AlpInvest Partners B.V. bought a new stake in Omada Health during the 2nd quarter worth about $1,182,000. GSA Capital Partners LLP acquired a new position in shares of Omada Health during the 2nd quarter worth about $1,289,000. BlackRock Inc. bought a new position in shares of Omada Health in the 2nd quarter valued at about $48,775,000. Finally, Quantinno Capital Management LP grew its holdings in shares of Omada Health by 464.1% in the 1st quarter. Quantinno Capital Management LP now owns 58,723 shares of the company’s stock valued at $738,000 after acquiring an additional 48,313 shares in the last quarter.
Omada Health Company Profile
Omada Health, Inc is a digital health company that provides virtual care programs for people managing chronic conditions. Its platform combines clinical care, health coaching, connected devices, digital tools and personalized support to help members improve health outcomes and manage conditions over time.
The company’s offerings address areas including diabetes, hypertension, weight health and musculoskeletal conditions. Omada’s programs are designed to support prevention and ongoing care through services such as remote monitoring, personalized health guidance, educational content and access to healthcare professionals.
Omada primarily serves members through employers, health plans and healthcare organizations in the United States.
Further Reading
- Five stocks we like better than Omada Health
- 3 Luxury Consumer Brands to Watch in a Beaten-Down Sector
- Jackson’s Record Quarter Powers the Bull Case
- Holiday Shopping Is Almost Here—And Target May Be Ready to Win Big
- AI Panic Hit Tech Stocks—But NVIDIA’s Growth Engine Is Intact
Receive News & Ratings for Omada Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omada Health and related companies with MarketBeat.com's FREE daily email newsletter.
